A new in vitro study has shown that aerosols from nicotine electronic cigarettes do not produce the cellular effects caused by cigarette smoke, which can lead to blood vessel damage and a range of heart diseases. It also found that aerosols from heated tobacco products produce far fewer adverse cellular effects compared to cigarettes. This research is crucial as smokers are two to four times more likely to suffer from heart disease than non-smokers, and one-fifth of smoking-related deaths are caused by cardiovascular diseases.
However, the significance of this study published last month goes beyond these specific findings. It is part of a replication initiative aimed at replicating the most famous studies conducted by tobacco companies to independently evaluate their scientific validity. The replication project aims to replicate ten international scientific studies, comparing the toxicity levels of traditional cigarette smoke, e-cigarettes, and heated products using human cells. The replication project is working to replace junk science with reliable data.
The project is being operated by the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR). The organization is headquartered in Sicily and has previously exposed deep methodological flaws in highly cited e-cigarette studies. It is now working to replace junk science with reliable data while recognizing that industry-funded research is often controlled by tobacco and ignored by broader public health organizations. Dr. Riccardo Polosa, founder of CoEHAR, told Filter: "By replicating the results of tobacco-funded research on e-cigarettes and heated tobacco products, we demonstrate that these results are reliable and trustworthy.
A new study conducted by an international research group affiliated with CoEHAR has been carried out in independent laboratories in Indonesia, Oman, Russia, Serbia, Greece, and the United States. This finding challenges the repeated claims by medical associations that using e-cigarettes or heated tobacco products is equally as dangerous as smoking, and advises patients to quit smoking and not switch. The American Heart Association stated on their website that "anyone who says e-cigarettes are safe is blowing smoke.
Researchers replicated a 2017 study by scientists at British American Tobacco (BAT), which showed that inhibition of endothelial cell migration caused by cigarette smoke, which lines the interior of the heart and blood vessels, is not caused by aerosol exposure from electronic cigarettes. "Our study again challenges the view that e-cigarettes or heated tobacco cause similar harm to combustible cigarettes," the Replica study, which used Vype ePen3, and heated tobacco products Glo Pro and IQOS 3 Duo, confirmed the results of the BAT study. It validates that transitioning to safer nicotine products can reduce harm and save lives.
An interesting fact is that switching to smoke-free products can decrease blood vessel damage and prevent the likelihood of smoking-related diseases such as atherosclerosis and high blood pressure. "Our study once again challenges the notion that e-cigarettes or heated tobacco cause similar damage to combustible cigarettes," said Dr. Massimo Caruso, lead author of the study and co-director of the replication project.
Statement
This article is compiled from third-party information and is intended for industry communication and educational purposes.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's content. The translation of this article is only for internal industry communication and research purposes.
Due to limitations in our translation abilities, the translated article may not accurately convey the same meaning as the original. Please refer to the original article for the most accurate information.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.
The copyright for compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
